Financial Performance - The company's operating revenue for Q3 2024 was ¥84,328,274.77, representing an increase of 8.11% year-over-year[2]. - The net profit attributable to shareholders for the same period was ¥10,022,302.73, a decrease of 12.75% compared to the previous year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥9,897,032.80, down 11.23% year-over-year[2]. - Total operating revenue for the first three quarters of 2024 reached ¥239,647,746.73, an increase of 17.3% compared to ¥204,245,593.58 in the same period of 2023[16]. - Net profit for the first three quarters of 2024 was ¥34,873,783.36, compared to ¥23,579,501.60 in 2023, representing a significant increase of 48.0%[18]. - Earnings per share for the first three quarters of 2024 were ¥0.43, up from ¥0.32 in the same period of 2023, indicating a growth of 34.4%[19]. - The company reported a gross profit of ¥16,822,154.41 for the first three quarters of 2024, compared to ¥23,508,172.93 in 2023, indicating a decrease of 28.6%[16]. - The total comprehensive income for the first three quarters of 2024 was ¥34,873,783.36, compared to ¥23,579,501.60 in 2023, showing an increase of 48.0%[19]. Research and Development - Research and development expenses totaled ¥6,995,122.48, an increase of 26.73% compared to the same period last year, accounting for 8.30% of operating revenue[3]. - Research and development expenses for the first three quarters of 2024 were ¥19,334,220.52, an increase from ¥16,428,167.12 in 2023, reflecting a growth of 17.5%[16]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,251,406,453.33, reflecting a 1.70% increase from the end of the previous year[3]. - The company's total assets amounted to approximately CNY 1,251.41 million, an increase from CNY 1,230.46 million at the end of 2023, reflecting a growth of about 1.7%[12]. - The total liabilities increased to ¥221,142,454.59 in 2024 from ¥203,192,380.09 in 2023, marking an increase of 8.8%[14]. - The company's total liabilities amounted to CNY 319.18 million, slightly down from CNY 319.79 million, showing a decrease of about 0.2%[12]. Cash Flow - The net cash flow from operating activities for the year-to-date period decreased by 54.23% to ¥4,771,459.61[2]. - In the first three quarters of 2024, the net cash flow from operating activities was 4,771,459.61, a decrease of 54.2% compared to 10,425,970.03 in the same period of 2023[20]. - The cash inflow from investment activities in the first three quarters of 2024 was 65,942,310.52, significantly up from 13,983,572.75 in the same period of 2023[22]. - The net cash flow from financing activities showed a negative value of -18,704,893.81 in 2024, compared to a positive 653,477,864.59 in 2023, indicating a substantial decline[22]. - The cash inflow from the recovery of investments was 65,942,310.52 in 2024, marking a significant increase compared to the previous year's figure[22]. Employee Compensation - The company reported a decrease in employee compensation payable from CNY 4.45 million to CNY 3.90 million, a decline of approximately 12.4%[13]. - The company paid 39,670,832.62 in employee compensation in 2023, which was an increase from 32,918,826.24 in 2022, reflecting a 20.5% rise[20]. Market and Strategic Developments - The company has not disclosed any new product developments or market expansion strategies in this report[1]. - The company continues to focus on expanding its market presence and developing new technologies, although specific details were not disclosed in the report[11]. - There were no significant changes in the company's operational strategies or mergers and acquisitions reported during this quarter[11].
华海诚科(688535) - 2024 Q3 - 季度财报